ESSA Pharma Inc. — Director's Dealing 2024

Mar 28, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ESSA Pharma Inc. (EPIX)
CIK: 0001633932
Period of Report: 2024-03-25

Reporting Person: Virsik Peter (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-25	Options	$9.04	A	110000	Acquired	2034-03-25	Common Shares (110000)	Direct

Footnotes

F1: Stock options vest and become exercisable over four years as follows: (i) 25% of the underlying shares vest one year after the grant date; and (ii) 75% of the remaining underlying shares vest in equal monthly installments over the following three years.